Adjustments for Share Splits Clause Example from Business Contracts

This example Adjustments for Share Splits clause appears in 10 contracts from 9 companies

Adjustments for Share Splits. The parties acknowledge and agree that all share-related numbers contained in this Agreement or any Terms Agreement shall be adjusted to take into account any share split, share dividend or similar event effected with respect to the Common Stock.
Found in Mirati Therapeutics, Inc. contract
Mirati Therapeutics, Inc. Contracts

Common Stock Sales Agreement between Mirati Therapeutics, Inc. and Cowen and Company, LLC (July 2, 2020) (Filed With SEC on July 2, 2020)

Editas Medicine, Inc. Contracts

Common Stock Sales Agreement between Editas Medicine, Inc. and Cowen and Company, LLC (May 15, 2020) (Filed With SEC on May 15, 2020)

Common Stock Sales Agreement between Editas Medicine, Inc. and Cowen and Company, LLC (May 14, 2021) (Filed With SEC on May 14, 2021)

FIVE PRIME THERAPEUTICS INC Contracts

Sales Agreement between Five Prime Therapeutics, Inc. and Cowen and Company, LLC for Up to $75,000,000 of Common Stock (Filed With SEC on August 6, 2020)

Molecular Templates, Inc. Contracts

Sales Agreement Between Molecular Templates, Inc. and Cowen and Company, LLC for Common Stock Offering (Filed With SEC on August 7, 2020)

SpringWorks Therapeutics, Inc. Contracts

Common Stock Sales Agreement between SpringWorks Therapeutics, Inc. and Cowen and Company, LLC (February 25, 2021) (Filed With SEC on February 25, 2021)

BioNano Genomics, Inc Contracts

Common Stock Sales Agreement between Bionano Genomics, Inc. and Cowen and Company, LLC (Filed With SEC on March 24, 2021)

Invitae Corp Contracts

Invitae Corporation Common Stock Sales Agreement with Cowen and Company, LLC (May 2021) (Filed With SEC on May 4, 2021)

Allakos Inc. Contracts

Sales Agreement between Allakos Inc. and Cowen and Company, LLC for Up to $400,000,000 of Common Stock (Filed With SEC on May 10, 2021)

Revolution Medicines, Inc. Contracts

Sales Agreement between Revolution Medicines, Inc. and Cowen and Company, LLC for Up to $250,000,000 of Common Stock (Filed With SEC on November 10, 2021)